Artera's ArteraAI Breast, cleared by the FDA on May 6, 2026, generates a metastasis risk score directly from biopsy slides without requiring additional genomic tissue testing.
Leica Biosystems' newly FDA-cleared Aperio iQC DX caught up to 24% more slide defects than histotechnicians while cutting manual quality-review time by 69%, the company says.
Merck and Google Cloud announced a multi-year, up-to-$1-billion partnership embedding Google engineers directly inside Merck's operations to deploy agentic AI across R&D, manufacturing and commercial functions.
A Nature paper from Nobel laureate David Baker's lab shows generative AI can design antibodies from scratch with atomic-level precision, bypassing the immune system entirely.
Florida's attorney general has sued OpenAI and Sam Altman directly, alleging the company hid safety risks and marketed ChatGPT to children despite knowing about dangerous failures.
Character.AI and Google have quietly settled five lawsuits alleging their chatbots contributed to teen suicides and mental-health harm, even as dozens more cases and state bills pile up nationally.
NVIDIA and Eli Lilly unveiled a five-year, $1 billion co-innovation AI lab in the San Francisco Bay Area, built on NVIDIA's BioNeMo platform, aiming to accelerate drug discovery, clinical development, and manufacturing.
GE HealthCare completed a $2.3 billion cash acquisition of Intelerad, a Montreal imaging-software company that manages over 230 million exams a year, betting outpatient imaging data and AI distribution matter more than scanner hardware alone.
Aidoc's CARE foundation model won FDA clearance to flag 14 acute conditions from a single abdominal CT scan, a consolidation the company says cuts false alerts roughly tenfold versus running separate single-purpose AI tools.
The NHS-linked GEMINI study found AI-assisted mammography screening increased breast cancer detection by 10.4% while cutting radiologist reading time by up to a third, intensifying pressure on other countries' screening programs.